+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Anemia Drug"

From
Anemia Drugs - Global Strategic Business Report - Product Thumbnail Image

Anemia Drugs - Global Strategic Business Report

  • Report
  • February 2025
  • 383 Pages
  • Global
From
From
From
Iron Deficiency Anemia - Pipeline Insight, 2024 - Product Thumbnail Image

Iron Deficiency Anemia - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Fanconi Anemia - Pipeline Insight, 2024 - Product Thumbnail Image

Fanconi Anemia - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
From
From
From
From
Darbepoetin Alfa (Aranesp) Market Report 2025 - Product Thumbnail Image

Darbepoetin Alfa (Aranesp) Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
From
Aplastic Anemia Market Report 2024 - Product Thumbnail Image

Aplastic Anemia Market Report 2024

  • Report
  • September 2024
  • 175 Pages
  • Global
From
From
From
Loading Indicator

The Anemia Drug market is a subset of the larger Hematological Drugs market, which includes drugs used to treat blood-related diseases. Anemia drugs are used to treat anemia, a condition in which the body does not produce enough healthy red blood cells. These drugs can be used to treat a variety of anemias, including iron deficiency anemia, aplastic anemia, and sickle cell anemia. Anemia drugs can be administered orally, intravenously, or intramuscularly, depending on the type of anemia being treated. Common anemia drugs include erythropoietin, darbepoetin, and epoetin alfa. Erythropoietin is a hormone that stimulates the production of red blood cells, while darbepoetin and epoetin alfa are synthetic versions of erythropoietin. Other anemia drugs include iron supplements, folic acid, and vitamin B12. Some companies in the Anemia Drug market include Amgen, Johnson & Johnson, Novartis, Pfizer, and Roche. Show Less Read more